IPSC Stock Summary and Trading Ideas (Century Therapeutics | NASDAQ:IPSC)

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

What symbol and exchange does Century Therapeutics shares trade?

Century Therapeutics trades on the NASDAQ stock market under the symbol IPSC.

What is Century Therapeutics stock price doing today?

As of April 21, 2026, IPSC stock price declined to $2.30 with 734,552 million shares trading.

What is Century Therapeutics's Beta?

IPSC has a beta of 1.24, meaning it tends to be more sensitive to market movements. IPSC has a correlation of 0.02 to the broad based SPY ETF.

How much is Century Therapeutics worth?

IPSC has a market cap of $413.36 million. This is considered a Small Cap stock.

How much money does Century Therapeutics make?

Last quarter Century Therapeutics reported $0 in Revenue and -$.25 earnings per share. This beat revenue expectation by $62,500 and exceeded earnings estimates by $.04.

What is the highest and lowest price Century Therapeutics traded in the last 3 year period?

In the last 3 years, IPSC traded as high as $5.51 and as low as $.34.

What are the top ETFs holding Century Therapeutics?

The top ETF exchange traded funds that IPSC belongs to (by Net Assets): VTI, VXF, DFAS, AVSC, PRFZ.

Is Century Therapeutics (IPSC) a good investment?

IPSC has outperformed the market in the last year with a return of +323.0%, while the SPY ETF gained +35.2%. In the last 3 month period, IPSC beat the market returning +19.8%, while SPY returned +4.2%. However, in the most recent 2 weeks IPSC has underperformed the stock market by returning +5.0%, while SPY returned +6.9%.

What are the support and resistance levels for Century Therapeutics (IPSC)?

IPSC support price is $2.20 and resistance is $2.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IPSC shares will trade within this expected range on the day.